Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Drug DiscoveryCRO

PUBLISHER: Grand View Research | PRODUCT CODE: 1985911

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1985911

Asia Pacific And Latin America Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report By Type, By Molecule Type, By Services, By Therapeutic Areas, By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

APAC & Latin America Pharmaceutical Contract Manufacturing Market Summary

The Asia Pacific and Latin America pharmaceutical contract manufacturing market size was valued at USD 21.56 billion in 2025 and is projected to reach USD 40.71 billion by 2033, growing at a CAGR of 8.39% from 2026 to 2033. The industry is driven by the growing number of generic drug approvals, growing clinical and commercial emphasis on biologic medicines and their biosimilar counterparts, and a strengthening regulatory framework.

The growing number of generic drug approvals is driving significant demand for high-volume manufacturing and remains a major structural driver of the Asia Pacific and Latin America pharmaceutical contract manufacturing market. According to the U.S. FDA Office of Generic Drugs, the agency approved 956 abbreviated new drug applications (ANDAs) in 2023 and 694 ANDAs in 2024, reflecting robust development activity in the global generic drug space.

A significant portion of the global pharmaceutical supply chain is concentrated in India and China, where India accounts for approximately 48% of all active pharmaceutical ingredient (API) Drug Master Files (DMFs) and China contributes 18%. Latin America is emerging as a key regional production hub, supported by favorable government policies and investments in local manufacturing capacity. This concentration enables pharmaceutical companies to leverage cost-efficient, scalable, and compliant production solutions, meeting growing global demand while reducing time-to-market pressures. The combination of rising approvals and concentrated manufacturing capacity ensures sustained outsourcing activity in these high-growth regions.

Asia Pacific And Latin America Pharmaceutical Contract Manufacturing Market Report Segmentation

This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Asia Pacific and Latin America pharmaceutical contract manufacturing market report based on type, molecule type, services, therapeutic area, and region:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Drug Discovery
    • Target Validation
    • Lead Identification
    • Lead Optimization
  • Pre-Clinical
  • Clinical
    • Phase I Trial Services
    • Phase II Trial Services
    • Phase III Trial Services
    • Phase IV Trial Services
  • Molecule Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Small Molecules
  • Large Molecules
  • Services Outlook (Revenue, USD Million, 2021 - 2033)
  • Project Management/Clinical Supply Management
  • Data Management
  • Regulatory/Medical Affairs
  • Medical Writing
  • Clinical Monitoring
  • Quality Management/ Assurance
  • Bio-statistics
  • Investigator Payments
  • Laboratory
  • Patient And Site Recruitment
  • Technology
  • Others
  • Therapeutic Areas Outlook (Revenue, USD Million, 2021 - 2033)
  • Oncology
  • CNS Disorders
  • Infectious Diseases
  • Immunological Disorders
  • Cardiovascular Disease
  • Respiratory Diseases
  • Diabetes
  • Ophthalmology
  • Pain Management
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
Show more
Product Code: GVR-4-68040-858-6

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Value chain-based analysis (Model 2)
    • 1.7.3. Multivariate Analysis (Model 3)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Landscape Insights

Chapter 3. Asia and Latin America Pharmaceutical Contract Manufacturing Market: Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Asia and Latin America Pharmaceutical Contract Manufacturing Market Dynamics
    • 3.2.1. Market Driver Impact Analysis
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Market Opportunities
  • 3.3. Technological Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. Tariff Impact Analysis
  • 3.6. Supply Chain Analysis
  • 3.7. Market Analysis Tools
    • 3.7.1. Porter's Five Forces Analysis
    • 3.7.2. PESTEL by SWOT Analysis

Chapter 4. Asia and Latin America Pharmaceutical Contract Manufacturing Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Asia and Latin America Pharmaceutical Contract Manufacturing Market Type Movement Analysis
  • 4.3. Asia and Latin America Pharmaceutical Contract Manufacturing Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
  • 4.4. Pre-clinical
    • 4.4.1. Drug Discovery Market Estimates and Forecasts, 2021 - 2033 (USD million)
  • 4.5. Drug Discovery
    • 4.5.1. Pre-Clinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Target Validation
      • 4.5.2.1. Target Validation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Lead Identification
      • 4.5.3.1. Lead Identification Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.4. Lead Optimization
      • 4.5.4.1. Lead Optimization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Clinical
    • 4.6.1. Clinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.2. Phase I Trial Services
      • 4.6.2.1. Phase I Trial Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.3. Phase II Trial Services
      • 4.6.3.1. Phase II Trial Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.4. Phase III Trial Services
      • 4.6.4.1. Phase III Trial Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.5. Phase IV Trial Services
      • 4.6.5.1. Phase IV Trial Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Asia and Latin America Pharmaceutical Contract Manufacturing Market: Molecule Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Asia and Latin America Pharmaceutical Contract Manufacturing Market Molecule Type Movement Analysis
  • 5.3. Asia and Latin America Pharmaceutical Contract Manufacturing Market Size & Trend Analysis, by Molecule Type, 2021 to 2033 (USD Million)
  • 5.4. Small Molecules
    • 5.4.1. Small Molecules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Large Molecules
    • 5.5.1. Large Molecules Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Asia and Latin America Pharmaceutical Contract Manufacturing Market: Services Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Asia and Latin America Pharmaceutical Contract Manufacturing Market Services Movement Analysis
  • 6.3. Asia and Latin America Pharmaceutical Contract Manufacturing Market Size & Trend Analysis, by Services, 2021 to 2033 (USD Million)
  • 6.4. Project Management/Clinical Supply Management
    • 6.4.1. Project Management/Clinical Supply Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Data Management
    • 6.5.1. Data Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Regulatory/Medical Affairs
    • 6.6.1. Regulatory/Medical Affairs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Medical Writing
    • 6.7.1. Medical Writing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Clinical Monitoring
    • 6.8.1. Clinical Monitoring Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.9. Quality Management/ Assurance
    • 6.9.1. Quality Management/ Assurance Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.10. Bio-statistics
    • 6.10.1. Bio-statistics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.11. Investigator Payments
    • 6.11.1. Investigator Payments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.12. Laboratory
    • 6.12.1. Laboratory Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.13. Patient And Site Recruitment
    • 6.13.1. Patient And Site Recruitment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.14. Technology
    • 6.14.1. Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.15. Others
    • 6.15.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Asia and Latin America Pharmaceutical Contract Manufacturing Market: Therapeutic Areas Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Asia and Latin America Pharmaceutical Contract Manufacturing Market Therapeutic Areas Movement Analysis
  • 7.3. Asia and Latin America Pharmaceutical Contract Manufacturing Market Size & Trend Analysis, by Therapeutic Areas, 2021 to 2033 (USD Million)
  • 7.4. Oncology
    • 7.4.1. Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. CNS Disorders
    • 7.5.1. CNS Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Infectious Diseases
    • 7.6.1. Infectious Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Immunological Disorders
    • 7.7.1. Immunological Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Cardiovascular Disease
    • 7.8.1. Cardiovascular Disease Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.9. Respiratory Diseases
    • 7.9.1. Respiratory Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.10. Diabetes
    • 7.10.1. Diabetes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.11. Ophthalmology
    • 7.11.1. Ophthalmology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.12. Pain Management
    • 7.12.1. Pain Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.13. Other
    • 7.13.1. Other Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Asia and Latin America Pharmaceutical Contract Manufacturing Market: Regional Estimates & Trend Analysis by Type, Molecule Type, Services, Therapeutic Area

  • 8.1. Regional Market Dashboard
  • 8.2. Regional Market Snapshot
  • 8.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.5. Australia
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.6. South Korea
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.7. Thailand
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. Argentina
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
    • 9.1.1. Market Leaders
    • 9.1.2. Emerging Players
  • 9.2. Asia and Latin America Pharmaceutical Contract Manufacturing Market Assessment Analysis, 2025
  • 9.3. Company Profiles
    • 9.3.1. WuXi STA
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Service Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Piramal Pharma Solutions
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Service Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Syngene International
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Service Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Samsung Biologics
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Service Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Jubilant Pharmova
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Service Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Celltrion
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Service Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Ajinomoto Bio-Pharma Services
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Service Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Almac Group
      • 9.3.8.1. Company Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Service Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Rubicon Research Pvt. Ltd.
      • 9.3.9.1. Company Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Service Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. Aurigene Pharmaceutical Services
      • 9.3.10.1. Company Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Service Benchmarking
      • 9.3.10.4. Strategic Initiatives
    • 9.3.11. Eurofarma Laboratorios S.A
      • 9.3.11.1. Company Overview
      • 9.3.11.2. Financial Performance
      • 9.3.11.3. Service Benchmarking
      • 9.3.11.4. Strategic Initiatives
    • 9.3.12. Unither Pharmaceuticals
      • 9.3.12.1. Company Overview
      • 9.3.12.2. Financial Performance
      • 9.3.12.3. Service Benchmarking
      • 9.3.12.4. Strategic Initiatives
    • 9.3.13. Fujifilm Diosynth Biotechnologies
      • 9.3.13.1. Company Overview
      • 9.3.13.2. Financial Performance
      • 9.3.13.3. Service Benchmarking
      • 9.3.13.4. Strategic Initiatives
    • 9.3.14. Patheon (Thermo Fisher Scientific)
      • 9.3.14.1. Company Overview
      • 9.3.14.2. Financial Performance
      • 9.3.14.3. Service Benchmarking
      • 9.3.14.4. Strategic Initiatives
    • 9.3.15. Pfizer
      • 9.3.15.1. Company Overview
      • 9.3.15.2. Financial Performance
      • 9.3.15.3. Service Benchmarking
      • 9.3.15.4. Strategic Initiatives
Show more
Product Code: GVR-4-68040-858-6

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Asia and Latin America Pharmaceutical Contract Manufacturing Market by Type, 2021 - 2033 (USD Million)
  • Table 4 Asia and Latin America Pharmaceutical Contract Manufacturing Market by Molecule Type, 2021 - 2033 (USD Million)
  • Table 5 Asia and Latin America Pharmaceutical Contract Manufacturing Market by Services, 2021 - 2033 (USD Million)
  • Table 6 Asia and Latin America Pharmaceutical Contract Manufacturing Market by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 7 Asia and Latin America Pharmaceutical Contract Manufacturing Market by Region, 2021 - 2033 (USD Million)
  • Table 8 Asia Pacific Pharmaceutical Contract Manufacturing Market by Country, 2021 - 2033 (USD Million)
  • Table 9 Japan Pharmaceutical Contract Manufacturing Market by Type, 2021 - 2033 (USD Million)
  • Table 10 Japan Pharmaceutical Contract Manufacturing Market by Molecule Type, 2021 - 2033 (USD Million)
  • Table 11 Japan Pharmaceutical Contract Manufacturing Market by Services, 2021 - 2033 (USD Million)
  • Table 12 Japan Pharmaceutical Contract Manufacturing Market by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 13 China Pharmaceutical Contract Manufacturing Market by Type, 2021 - 2033 (USD Million)
  • Table 14 China Pharmaceutical Contract Manufacturing Market by Molecule Type, 2021 - 2033 (USD Million)
  • Table 15 China Pharmaceutical Contract Manufacturing Market by Services, 2021 - 2033 (USD Million)
  • Table 16 China Pharmaceutical Contract Manufacturing Market by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 17 India Pharmaceutical Contract Manufacturing Market by Type, 2021 - 2033 (USD Million)
  • Table 18 India Pharmaceutical Contract Manufacturing Market by Molecule Type, 2021 - 2033 (USD Million)
  • Table 19 India Pharmaceutical Contract Manufacturing Market by Services, 2021 - 2033 (USD Million)
  • Table 20 India Pharmaceutical Contract Manufacturing Market by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 21 South Korea Pharmaceutical Contract Manufacturing Market by Type, 2021 - 2033 (USD Million)
  • Table 22 South Korea Pharmaceutical Contract Manufacturing Market by Molecule Type, 2021 - 2033 (USD Million)
  • Table 23 South Korea Pharmaceutical Contract Manufacturing Market by Services, 2021 - 2033 (USD Million)
  • Table 24 South Korea Pharmaceutical Contract Manufacturing Market by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 25 Thailand Pharmaceutical Contract Manufacturing Market by Type, 2021 - 2033 (USD Million)
  • Table 26 Thailand Pharmaceutical Contract Manufacturing Market by Molecule Type, 2021 - 2033 (USD Million)
  • Table 27 Thailand Pharmaceutical Contract Manufacturing Market by Services, 2021 - 2033 (USD Million)
  • Table 28 Thailand Pharmaceutical Contract Manufacturing Market by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 29 Australia Pharmaceutical Contract Manufacturing Market by Type, 2021 - 2033 (USD Million)
  • Table 30 Australia Pharmaceutical Contract Manufacturing Market by Molecule Type, 2021 - 2033 (USD Million)
  • Table 31 Australia Pharmaceutical Contract Manufacturing Market by Services, 2021 - 2033 (USD Million)
  • Table 32 Australia Pharmaceutical Contract Manufacturing Market by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 33 Latin America Pharmaceutical Contract Manufacturing Market by Type, 2021 - 2033 (USD Million)
  • Table 34 Latin America Pharmaceutical Contract Manufacturing Market by Molecule Type, 2021 - 2033 (USD Million)
  • Table 35 Latin America Pharmaceutical Contract Manufacturing Market by Services, 2021 - 2033 (USD Million)
  • Table 36 Latin America Pharmaceutical Contract Manufacturing Market by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 37 Brazil Pharmaceutical Contract Manufacturing Market by Type, 2021 - 2033 (USD Million)
  • Table 38 Brazil Pharmaceutical Contract Manufacturing Market by Molecule Type, 2021 - 2033 (USD Million)
  • Table 39 Brazil Pharmaceutical Contract Manufacturing Market by Services, 2021 - 2033 (USD Million)
  • Table 40 Brazil Pharmaceutical Contract Manufacturing Market by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 41 Argentina Pharmaceutical Contract Manufacturing Market by Type, 2021 - 2033 (USD Million)
  • Table 42 Argentina Pharmaceutical Contract Manufacturing Market by Molecule Type, 2021 - 2033 (USD Million)
  • Table 43 Argentina Pharmaceutical Contract Manufacturing Market by Services, 2021 - 2033 (USD Million)
  • Table 44 Argentina Pharmaceutical Contract Manufacturing Market by Therapeutic Area, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Asia and Latin America Pharmaceutical Contract Manufacturing market segmentation
  • Fig. 3 Market research process
  • Fig. 4 Information procurement
  • Fig. 5 Data Analysis Models
  • Fig. 6 Market Formulation And Validation
  • Fig. 7 Data Validating & Publishing
  • Fig. 8 Commodity flow analysis
  • Fig. 9 Primary interviews in North America
  • Fig. 10 Primary interviews in Europe
  • Fig. 11 Primary interviews in Asia Pacific
  • Fig. 12 Primary interviews in Latin America
  • Fig. 13 Primary interviews in MEA
  • Fig. 14 Market Snapshot
  • Fig. 15 Segment Snapshot
  • Fig. 16 Segment Snapshot
  • Fig. 17 Competitive Landscape Snapshot
  • Fig. 18 Parent market outlook, 2025 (USD Million)
  • Fig. 19 Ancillary market outlook, 2025 (USD Million)
  • Fig. 20 Current shared services and outsourcing usage levels
  • Fig. 21 Porter's five forces analysis
  • Fig. 22 Asia and Latin America Pharmaceutical Contract Manufacturing market: PESTEL analysis
  • Fig. 23 Clinical trial scenario (2022)
  • Fig. 24 Asia and Latin America Pharmaceutical Contract Manufacturing market type outlook: Segment dashboard
  • Fig. 25 Asia and Latin America Pharmaceutical Contract Manufacturing market, by type segment: market share, 2025 & 2033
  • Fig. 26 Drug Discovery market, 2021 - 2033 (USD Million)
  • Fig. 27 Pre-Clinical market, 2021 - 2033 (USD Million)
  • Fig. 28 Clinical market, 2021 - 2033 (USD Million)
  • Fig. 29 Asia and Latin America Pharmaceutical Contract Manufacturing market type outlook: Segment dashboard
  • Fig. 30 Asia and Latin America Pharmaceutical Contract Manufacturing market, by type segment: market share, 2025 & 2033
  • Fig. 31 Drug Discovery market, 2021 - 2033 (USD Million)
  • Fig. 32 Target Validation market, 2021 - 2033 (USD Million)
  • Fig. 33 Lead Identification market, 2021 - 2033 (USD Million)
  • Fig. 34 Lead Optimization market, 2021 - 2033 (USD Million)
  • Fig. 35 Pre-Clinical market, 2021 - 2033 (USD Million)
  • Fig. 36 Clinical market, 2021 - 2033 (USD Million)
  • Fig. 37 Phase I Trial Services market, 2021 - 2033 (USD Million)
  • Fig. 38 Phase II Trial Services market, 2021 - 2033 (USD Million)
  • Fig. 39 Phase III Trial Services market, 2021 - 2033 (USD Million)
  • Fig. 40 Phase IV Trial Services market, 2021 - 2033 (USD Million)
  • Fig. 41 Asia and Latin America Pharmaceutical Contract Manufacturing market molecule type outlook: Segment dashboard
  • Fig. 42 Asia and Latin America Pharmaceutical Contract Manufacturing market, by molecule type segment: market share, 2025 & 2033
  • Fig. 43 Small Molecules market, 2021 - 2033 (USD Million)
  • Fig. 44 Large Molecules market, 2021 - 2033 (USD Million)
  • Fig. 45 Asia and Latin America Pharmaceutical Contract Manufacturing market services outlook: Segment dashboard
  • Fig. 46 Asia and Latin America Pharmaceutical Contract Manufacturing market, by services segment: market share, 2025 & 2033
  • Fig. 47 Project Management/Clinical Supply Management market, 2021 - 2033 (USD Million)
  • Fig. 48 Data Management market, 2021 - 2033 (USD Million)
  • Fig. 49 Regulatory/Medical Affairs market, 2021 - 2033 (USD Million)
  • Fig. 50 Medical Writing market, 2021 - 2033 (USD Million)
  • Fig. 51 Clinical Monitoring market, 2021 - 2033 (USD Million)
  • Fig. 52 Quality Management/ Assurance market, 2021 - 2033 (USD Million)
  • Fig. 53 Bio-statistics market, 2021 - 2033 (USD Million)
  • Fig. 54 Investigator Payments market, 2021 - 2033 (USD Million)
  • Fig. 55 Laboratory market, 2021 - 2033 (USD Million)
  • Fig. 56 Patient And Site Recruitment market, 2021 - 2033 (USD Million)
  • Fig. 57 Technology market, 2021 - 2033 (USD Million)
  • Fig. 58 Others market, 2021 - 2033 (USD Million)
  • Fig. 59 Asia and Latin America Pharmaceutical Contract Manufacturing market therapeutic area outlook: Segment dashboard
  • Fig. 60 Asia and Latin America Pharmaceutical Contract Manufacturing market, by therapeutic area segment: market share, 2025 & 2033
  • Fig. 61 Oncology market, 2021 - 2033 (USD Million)
  • Fig. 62 CNS Disorders market, 2021 - 2033 (USD Million)
  • Fig. 63 Infectious Diseases market, 2021 - 2033 (USD Million)
  • Fig. 64 Immunological Disorders market, 2021 - 2033 (USD Million)
  • Fig. 65 Cardiovascular Disease market, 2021 - 2033 (USD Million)
  • Fig. 66 Respiratory Diseases market, 2021 - 2033 (USD Million)
  • Fig. 67 Diabetes market, 2021 - 2033 (USD Million)
  • Fig. 68 Ophthalmology market, 2021 - 2033 (USD Million)
  • Fig. 69 Pain Management market, 2021 - 2033 (USD Million)
  • Fig. 70 Other market, 2021 - 2033 (USD Million)
  • Fig. 71 Asia and Latin America Pharmaceutical Contract Manufacturing market revenue, by region, 2025 & 2033 (USD Million)
  • Fig. 72 Regional marketplace: Key takeaways
  • Fig. 73 Asia Pacific Pharmaceutical Contract Manufacturing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Japan Pharmaceutical Contract Manufacturing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 China Pharmaceutical Contract Manufacturing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 India Pharmaceutical Contract Manufacturing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Australia Pharmaceutical Contract Manufacturing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 South Korea Pharmaceutical Contract Manufacturing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Thailand Pharmaceutical Contract Manufacturing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Latin America Pharmaceutical Contract Manufacturing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Brazil Pharmaceutical Contract Manufacturing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 Argentina Pharmaceutical Contract Manufacturing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Argentina Pharmaceutical Contract Manufacturing market estimates and forecasts, 2021 - 2033 (USD Million)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!